Study on the Correlation Between Neurotrophic Factors and the Condition of Stroke Patients
Clinical Study of the Relationship Between Different Interventions for Post-stroke Functional Impairment and Neurotrophic Factors
1 other identifier
interventional
300
1 country
1
Brief Summary
Stroke is currently the most common disabling disease, which often leads to impairment of sensory, motor, speech and psychological functions, resulting in a reduced quality of life for patients. Therefore, post-stroke functional rehabilitation, especially the rehabilitation of physical function and psychological condition, is particularly important for patients to rejoin society. Acupuncture can promote the functional recovery of patients and facilitate the rehabilitation of limb function, thus improving the quality of survival of post-stroke patients. Neurotrophic factors are diverse, most of which are mainly derived from neuronal cells in the central nervous system and are involved in a variety of neurological functions such as cell growth, differentiation and plasticity, thus promoting recovery of multiple functions after stroke. Many studies have found that different interventions affect the prognosis of stroke patients differently, e.g., long-term acupuncture increases serum levels of brain-derived neurotrophic factor in stroke patients and also has better outcomes than controls in post-stroke neurological recovery and the development of post-stroke psychiatric disorders. This study investigated the effects of different therapeutic measures on patients' functional recovery and neurotrophic factors by setting up a controlled and blinded trial design, which could not only provide clinical evidence for the effectiveness of relevant therapeutic measures, but also verify the clinical value of certain neurotrophic factors (e.g., predicting outcome, assessing condition, and preventing adverse events).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Nov 2021
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 16, 2021
CompletedFirst Submitted
Initial submission to the registry
July 21, 2022
CompletedFirst Posted
Study publicly available on registry
July 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 29, 2022
July 1, 2022
3.1 years
July 21, 2022
July 27, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
modified rankin scale
The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending
Change of the score of modified rankin scale from Baseline at 1 week after onset of disease
modified rankin scale
The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending
Change of the score of modified rankin scale from Baseline at 2 weeks after onset of disease
modified rankin scale
The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending
Change of the score of modified rankin scale from Baseline at 1 month after onset of disease
modified rankin scale
The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending
Change of the score of modified rankin scale from Baseline at 2 months after onset of disease
modified rankin scale
The mrs (modified rankin scale) is a scale used to assess the patient's ability to care for himself/herself, which is composed of independent walking ability, self-perceived symptoms, and ability to control bowel and urine.Assessment results range from 0-6 points,a higher score means a worse ending
Change of the score of modified rankin scale from Baseline at 3 months after onset of disease
Secondary Outcomes (1)
Mini-mental State Examination
Change of the score of modified rankin scale from Baseline at 1 week, 2 weeks, 1 month, 2 months, 3 months after onset of disease
Study Arms (7)
acupuncture stroke group
EXPERIMENTALsham acupuncture stroke group
SHAM COMPARATORno acupuncture stroke group
PLACEBO COMPARATORacupuncture healthy group
PLACEBO COMPARATORcomputerized cognitive training group
EXPERIMENTALtranditional cognitive training group
PLACEBO COMPARATORaerobics group
EXPERIMENTALInterventions
Manual acupuncture or electro-acupuncture by experienced acupuncturists for patients
One-on-one cognitive training by an experienced cognitive therapist, combined with an existing computerized cognitive training system
Patients are trained by experienced physical therapists with the help of elastic bands and physical therapy devices
One-on-one cognitive training with an experienced cognitive therapist, combined with traditional cognitive training methods (e.g., balls, cards, counting, daily conversation, etc.)
Treatment of underlying disease and stroke according to guidelines, as well as necessary care and rehabilitation
Eligibility Criteria
You may qualify if:
- Symptom recognition to admission ≤ 72 hours
- Clear imaging evidence
- Diagnosis of spontaneous cerebral hemorrhage by an immobilized physician according to relevant guidelines; pre-onset mRS score ≤ 1
You may not qualify if:
- This onset was caused by traumatic and violent factors
- History of previous intracranial surgery
- Previous cerebrovascular accident
- Previous speech disorders and limb movement disorders
- Participation in other trials in the last three months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yongchuan Hospital of Chongqing Medical University
Chongqing, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.S. in Medicine
Study Record Dates
First Submitted
July 21, 2022
First Posted
July 29, 2022
Study Start
November 16, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
July 29, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share